Cellectis
CLLS
34 hedge funds and large institutions have $29.3M invested in Cellectis in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 12 closing their positions.
60% more capital invested
Capital invested by funds: $18.3M → $29.3M (+$11M)
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
8.15% more ownership
Funds ownership: 19.2% → 27.35% (+8.1%)
15% less funds holding
Funds holding: 40 → 34 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Bpifrance
Maisons Alfort, Cedex,
France
|
+$5.48M |
| 2 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$4.52M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$3.51M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$2.6M |
| 5 |
Millennium Management
New York
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$525K |
| 2 |
Jane Street
New York
|
-$403K |
| 3 |
D.E. Shaw & Co
New York
|
-$262K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$122K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$122K |
CLLS Hedge Fund Activity: Q1 2023 in Review
34 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2023, worth a combined $29.3M — up 60% from $18.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CLLS and 6 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 11 added.
The largest buyer was Bpifrance, opening a new position worth an estimated $5.48M. The largest seller was Capital World Investors, exiting entirely with an estimated $525K sold.
- 34 institutional investors held Cellectis (CLLS) as of Q1 2023, down from 40 in Q4 2022.
- Funds reported $29.3M of Cellectis stock for Q1 2023, up 60% quarter-over-quarter.
- 6 funds opened new Cellectis positions in Q1 2023 and 12 closed out, a net change of -6 holders.
- The largest Cellectis buyer in Q1 2023 was Bpifrance, an estimated $5.48M added.
- The largest Cellectis seller in Q1 2023 was Capital World Investors, an estimated $525K sold.
Based on aggregated 13F filings for Q1 2023.